发布求助
文献互助 智能选刊 最新文献

Advances in Clinical Neuroscience Rehabilitation最新文献

筛选
英文 中文
Making information accessible for people with aphasia in healthcare 使失语症患者在医疗保健方面能够获得信息
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2022-01-19 DOI: 10.47795/wkdo3084
Simon Grobler, Sarah Casey, E. Farrell
{"title":"Making information accessible for people with aphasia in healthcare","authors":"Simon Grobler, Sarah Casey, E. Farrell","doi":"10.47795/wkdo3084","DOIUrl":"https://doi.org/10.47795/wkdo3084","url":null,"abstract":"People with aphasia are often unable to access healthcare due to difficulties understanding and using spoken and written language, which impacts every step of their healthcare journey and outcomes. This article argues that it is important to apply the principles of the NHS England Accessible Information Standards (2017) to people with aphasia so they can meet their health information needs and rights. The processes to enable people with aphasia to access and participate in spoken and written communication in healthcare and the methods for training and supporting healthcare staff need to be considered at an individual, service, and organisational level.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76186266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Dietary restriction in multiple sclerosis: evidence from preclinical and clinical studies 多发性硬化症的饮食限制:来自临床前和临床研究的证据
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2022-01-19 DOI: 10.47795/mcln8939
E. Liao, L. Ghezzi, L. Piccio
{"title":"Dietary restriction in multiple sclerosis: evidence from preclinical and clinical studies","authors":"E. Liao, L. Ghezzi, L. Piccio","doi":"10.47795/mcln8939","DOIUrl":"https://doi.org/10.47795/mcln8939","url":null,"abstract":"Dietary restriction (DR) interventions, which encompass both chronic and intermittent reductions in energy intake, are emerging as potential therapeutic approaches for dampening neuroinflammation and demyelination in multiple sclerosis (MS). Mechanisms mediating the beneficial effects of DR include the regulation of pro- and anti-inflammatory signalling molecules and gut microbiome remodelling. This article summarises the preclinical evidence supporting the role of DR in attenuating disease in animal models of MS and the developing clinical evidence indicating the safety and feasibility of such DR interventions in people with MS (pwMS).","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83543243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological literature: Headache 10 神经学文献:头痛
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2022-01-17 DOI: 10.47795/fsbo8516
A. Larner
{"title":"Neurological literature: Headache 10","authors":"A. Larner","doi":"10.47795/fsbo8516","DOIUrl":"https://doi.org/10.47795/fsbo8516","url":null,"abstract":"","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80953479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebrospinal fluid hydrothorax in a rehabilitation medicine patient following thoracotomy for thoracic disc protrusion 康复医学患者胸椎椎间盘突出术后的脑脊液胸水
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2022-01-01 DOI: 10.47795/jati7770
Adam Boardman, Salman Lari, A. Manuel, Roberta Shaw, Simon R Clark
{"title":"Cerebrospinal fluid hydrothorax in a rehabilitation medicine patient following thoracotomy for thoracic disc protrusion","authors":"Adam Boardman, Salman Lari, A. Manuel, Roberta Shaw, Simon R Clark","doi":"10.47795/jati7770","DOIUrl":"https://doi.org/10.47795/jati7770","url":null,"abstract":"Cerebrospinal fluid (CSF) hydrothorax has been reported most commonly as a complication of ventriculo-pleural/-peritoneal shunt insertion, but also due to duro-pleural fistula. Here we report a case of CSF hydrothorax in a rehabilitation patient due to duro-pleural fistula following thoracotomy for thoracic myelopathy secondary to disc protrusion. This case highlights the need for high clinical suspicion following thoracotomy, and urgent specialist input from the neurosurgical team.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88951670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Migraine in perimenopausal women 围绝经期妇女的偏头痛
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2022-01-01 DOI: 10.47795/sbkp2228
A. Macgregor
{"title":"Migraine in perimenopausal women","authors":"A. Macgregor","doi":"10.47795/sbkp2228","DOIUrl":"https://doi.org/10.47795/sbkp2228","url":null,"abstract":"There is an unmet need for effective diagnosis and management of migraine in perimenopausal women. Menstrual cycle hormone disruption during perimenopause is associated with an increase in migraine and menstrual migraine prevalence, together with other more commonly recognised menopause symptoms. Women of perimenopause age, i.e., early 40s to mid 50s, should routinely be asked about migraine and menopause symptoms, and provided with effective tools for management as appropriate. Simple diaries can be used to identify the frequency and duration of attacks, as well as the relationship to menstruation at outset, and to monitor response to treatment. While there is no evidence to support prescription of hormone replacement therapy (HRT) solely for management of migraine, it is the most commonly used treatment for menopause symptoms. As some types and regimens of HRT can negatively affect migraine, the general recommendation is to use transdermal oestrogen and continuous progestogen regimens where possible. In contrast to contraceptive synthetic oestrogens, physiological doses of natural oestrogen can be used by women with migraine aura. Most women, particularly those with a history of menstrual migraine, can be reassured that the natural history of migraine is to improve with increasing years post menopause.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74600271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progressive Supranuclear Palsy in 2022: recent developments and an eye to the future 2022年进行性核上性麻痹:最近的发展和对未来的展望
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2022-01-01 DOI: 10.47795/hmmc8661
S. Lyons, S. O’Dowd, R. Walsh, Tim Lynch
{"title":"Progressive Supranuclear Palsy in 2022: recent developments and an eye to the future","authors":"S. Lyons, S. O’Dowd, R. Walsh, Tim Lynch","doi":"10.47795/hmmc8661","DOIUrl":"https://doi.org/10.47795/hmmc8661","url":null,"abstract":"Progressive supranuclear palsy (PSP) is an uncommon, progressive, neurodegenerative condition which classically presents with eye movement abnormalities, axial rigidity, early falls and cognitive impairment. The range of recognised phenotypes associated with PSP has expanded significantly in recent years. Imaging markers can assist in the diagnosis of PSP, while novel imaging modalities and laboratory-based biomarkers offer hope for earlier and more accurate diagnosis. While no disease modifying treatments are yet available several therapies may be useful in ameliorating symptoms. Despite disappointing recent clinical trial results, several agents are currently under investigation for the treatment of PSP.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77338126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keeping people with aphasia worldwide “COVID-informed” amid and after the pandemic 让全球失语症患者在大流行期间和之后“了解covid - 19”
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2021-12-15 DOI: 10.47795/qhxc5791
Anthony Pak-Hin Kong
{"title":"Keeping people with aphasia worldwide “COVID-informed” amid and after the pandemic","authors":"Anthony Pak-Hin Kong","doi":"10.47795/qhxc5791","DOIUrl":"https://doi.org/10.47795/qhxc5791","url":null,"abstract":"Aphasia is an acquired language disorder commonly caused by a stroke or brain injury. A slowly growing number of studies have emerged reporting the psychosocial disruptions experienced by people with aphasia (PWA) in the present COVID-19 pandemic. To extend this topic of better addressing PWA’s rehabilitation needs, this paper aims to draw attention to the significance of helping PWA stay “COVID-informed” through the use of resources that are communicatively-accessible. Keeping PWA abreast of the evolution of the pandemic can reasonably ensure they stay connected to their society, even without an actual physical presence in their community. However, aphasia-friendly health information is currently available predominantly in English only. Similar materials are relatively scarce in other languages and not necessarily updated, albeit such a need for these resources is apparent globally. It is essential that healthcare providers ensure that accessible, comprehensible, high-quality and reliable health-related resources are made available for PWA; this will ultimately benefit them to navigate the pandemic and prepare for the post-COVID era.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"107 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79561764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disease modifying treatments for Parkinson’s disease – an update 帕金森氏病的疾病修饰治疗——最新进展
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2021-12-02 DOI: 10.47795/jhqt7239
V. Chandran, D. Grosset
{"title":"Disease modifying treatments for Parkinson’s disease – an update","authors":"V. Chandran, D. Grosset","doi":"10.47795/jhqt7239","DOIUrl":"https://doi.org/10.47795/jhqt7239","url":null,"abstract":"An improved understanding of the pathological processes leading to neurodegeneration in Parkinson’s disease (PD) is leading to the development of a number of disease modifying agents. These include both novel and repurposed drugs. Some of these disease modifying therapies act on cellular targets that have been identified by genetic mutations, while others act on other cellular process which we know are affected in PD. This review provides an update on the progress in the field, and highlights some areas of special interest.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83171567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
George Smith: A historical vignette 乔治·史密斯:一个历史小插曲
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2021-12-02 DOI: 10.47795/afst2742
N. Agarwal, Pragnesh Bhatt
{"title":"George Smith: A historical vignette","authors":"N. Agarwal, Pragnesh Bhatt","doi":"10.47795/afst2742","DOIUrl":"https://doi.org/10.47795/afst2742","url":null,"abstract":"","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76714683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Migralepsy explained … perhaps‽ 偏头痛解释…也许‽
Advances in Clinical Neuroscience Rehabilitation Pub Date : 2021-09-08 DOI: 10.47795/ytqd4039
A. Larner
{"title":"Migralepsy explained … perhaps‽","authors":"A. Larner","doi":"10.47795/ytqd4039","DOIUrl":"https://doi.org/10.47795/ytqd4039","url":null,"abstract":"","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47852855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书